HAL
41
11
PNW
49
4
AKAM
48
-11
CMA
39
3
AVGO
57
-14
KHC
29
2
ADT
55
25
AA
38
3
CRM
59
4
ICE
67
3
CFG
34
4
EL
45
2
VRSK
89
2
DO
45
2
CSCO
53
2
ECL
84
14
GIS
54
2
INTC
47
6
DNB
36
2
BF.B
53
5
HAL
41
11
PNW
49
4
AKAM
48
-11
CMA
39
3
AVGO
57
-14
KHC
29
2
ADT
55
25
AA
38
3
CRM
59
4
ICE
67
3
CFG
34
4
EL
45
2
VRSK
89
2
DO
45
2
CSCO
53
2
ECL
84
14
GIS
54
2
INTC
47
6
DNB
36
2
BF.B
53
5
Financhill
Back

Pacific Biosciences of California Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
30

PACB
Pacific Biosciences of California

Last Price:
1.47
Seasonality Move:
13.38%
Sell
43

RARE
Ultragenyx Pharmaceutical

Last Price:
39.58
Seasonality Move:
3.65%
Sell
30
Pacific Biosciences of California (PACB) is a Sell

Is Pacific Biosciences of California a Buy, Sell or Hold?

  • The current Pacific Biosciences of California [PACB] share price is $1.47. The Score for PACB is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • PACB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.60. The Score for RARE is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PACB Stock Price Chart

What is Pacific Biosciences of California's stock price today?

  • The Pacific Biosciences of California share price today is $1.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PACB is experiencing selling pressure, which indicates risk of future bearish movement.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.60
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

PACB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 34.52 Sell
Chaikin Money Flow: -9169623 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.71 - 2.01) Sell
Bollinger Bands (100): (1.6 - 5.1) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.73 Sell
Relative Strength Index (14 RSI): 45.77 Sell
Chaikin Money Flow: 722527 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.99 - 42.29) Sell
Bollinger Bands (100): (41.03 - 48.83) Sell

PACB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.72 Sell
20-day SMA: 1.83 Sell
50-day SMA: 1.86 Sell
200-day SMA: 5.84 Sell
8-day EMA: 1.68 Sell
20-day EMA: 1.8 Sell
50-day EMA: 2.23 Sell
200-day EMA: 5.28 Sell

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 40.38 Sell
20-day SMA: 40.41 Sell
50-day SMA: 41.94 Sell
200-day SMA: 42.46 Sell
8-day EMA: 39.76 Sell
20-day EMA: 40.54 Sell
50-day EMA: 42.03 Sell
200-day EMA: 43.46 Sell

Pacific Biosciences of California Earnings Growth & PACB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.01 per share, an increase this year of $0.27 per share, and an increase next year of $0.17 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.49 per share, an increase next quarter of $0.01 per share, an increase this year of $0.90 per share, and an increase next year of $1.07 per share.

Pacific Biosciences of California Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):